GNS Healthcare to Present Innovative Efficacy to Real-World Effectiveness Solution at ISPOR Europe

Breakthrough GNS Causal Machine Learning Platform REFSTM Predicts Real-World Patient Outcomes Prior to Market Launch; Novartis and Harvard Scientists Collaborate to Demonstrate its Power CAMBRIDGE, Mass.–(BUSINESS WIRE)–Leading precision medicine company GNS Healthcare (GNS) will reveal a causal machine learning and data-driven solution, “Efficacy to Effectiveness,” at the ISPOR 19th Annual European Congress in Vienna, Austria. The solution, demonstrated in collaboration with global healthcare leader Novartis (NYSE: NVS and SIX: NOVN) and Harvard University scientists, predicts how new therapeutics will perform in the real world across a variety of specific populations, informing pharmaceutical makers’ pre-launch market access strategies and generating evidence to support value-based contracting upon launch of a new therapeutic. The presentation will describe use of solely pre-launch data in a retrospective study to predict real-world outcomes of a multiple…


Link to Full Article: GNS Healthcare to Present Innovative Efficacy to Real-World Effectiveness Solution at ISPOR Europe

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!